---
title: "rufinamide - Lennox-Gastaut syndrome"
sidebar: mydoc_sidebar
permalink: rufinamidelennoxgastautsyndrome2.html
toc: false 
---

{% include image.html url="images/rufinamidelennoxgastautsyndrome2.png" file="rufinamidelennoxgastautsyndrome2.png" alt="rufinamidelennoxgastautsyndrome2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C079703 | rufinamide | Drug |
| UniProt:P41594 | Metabotropic glutamate receptor 5 | Protein |
| GO:0099530 | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential | MolecularActivity |
| GO:0035249 | synaptic transmission, glutamatergic | BiologicalProcess |
| HP:0032792 | Tonic seizure | PhenotypicFeature |
| MESH:D065768 | Lennox-Gastaut syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Rufinamide | DECREASES ACTIVITY OF | Metabotropic Glutamate Receptor 5 |
| Metabotropic Glutamate Receptor 5 | POSITIVELY CORRELATED WITH | G Protein-Coupled Receptor Activity Involved In Regulation Of Postsynaptic Membrane Potential |
| G Protein-Coupled Receptor Activity Involved In Regulation Of Postsynaptic Membrane Potential | POSITIVELY CORRELATED WITH | Synaptic Transmission, Glutamatergic |
| Synaptic Transmission, Glutamatergic | POSITIVELY CORRELATED WITH | Tonic Seizure |
| Tonic Seizure | POSITIVELY CORRELATED WITH | Lennox-Gastaut Syndrome |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB06201#mechanism-of-action](https://go.drugbank.com/drugs/DB06201#mechanism-of-action){:target="_blank"}